ArticleNPJ precision oncology2026

Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner.

Aymeric Zadoroznyj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.